Trial Profile
A phase II study of TAK-272 for early stage diabetic nephropathy and/or hypertension
Status:
Planning
Phase of Trial:
Phase II
Latest Information Update: 15 Mar 2017
Price :
$35
*
At a glance
- Drugs Imarikiren (Primary)
- Indications Diabetic nephropathies; Hypertension
- Focus Therapeutic Use
- 15 Mar 2017 New trial record